GENFIT Logo

GENFIT

Develops therapies and diagnostics for patients with rare and severe liver diseases.

GNFT | PA

Overview

Corporate Details

ISIN(s):
FR0004163111 (+2 more)
LEI:
969500XPWN2DMZQA5X73
Country:
France
Address:
885 AVENUE EUGENE AVINEE, 59120 LOOS

Description

GENFIT is a biopharmaceutical company dedicated to developing therapeutic and diagnostic solutions for patients with rare and severe liver diseases characterized by high unmet medical needs. The company's primary focus is on Acute-on-Chronic Liver Failure (ACLF) and its associated conditions, such as acute decompensation (AD) and hepatic encephalopathy (HE). Leveraging a scientific heritage of over two decades, GENFIT is a pioneer in liver disease research and development, aiming to improve the lives of patients with these life-threatening conditions.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2017-05-05 08:30
2017.05.05 PR GENFIT 1st patient PBC
English 333.1 KB
2017-04-28 21:45
2017.04.28 PR GENFIT Mise à disposition DDR
English 72.2 KB
2017-04-28 21:45
2017.04.28 CP GENFIT Mise à disposition DDR
French 78.4 KB
2017-04-05 10:44
2017.04.05 PR GENFIT EASL ILC 2017
English 301.6 KB
2017-04-05 10:44
2017.04.05 CP GENFIT EASL ILC 2017
French 389.7 KB
2017-03-28 08:30
2017.03.28 CP GENFIT KOLs events
French 294.6 KB
2017-03-28 08:30
2017.03.28 PR GENFIT KOLs events
English 307.7 KB
2017-02-14 08:30
2017.02.14 CP GENFIT Evenement inaugural NASH EP
French 341.5 KB
2017-02-14 08:30
2017.02.14 GENFIT PR Inaugural Event NASH EP
English 408.6 KB
2017-01-10 17:45
2017.01.10 PR GENFIT Half year report of liquidity contract
English 282.9 KB
2017-01-10 17:45
2017.01.10 CP GENFIT Bilan semestriel contrat de liquidité
French 273.0 KB
2017-01-09 17:45
2017.01.09 CP GENFIT Calendrier Financier 2017
French 288.7 KB
2017-01-09 17:45
2017.01.09 PR GENFIT 2017 Financial Calendar
English 774.6 KB
2016-12-14 18:00
2016.12.14 CP GENFIT NASH Education Program
French 368.6 KB
2016-12-14 18:00
2016.12.14 PR GENFIT NASH Education Program
English 354.7 KB

Automate Your Workflow. Get a real-time feed of all GENFIT filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GENFIT

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GENFIT via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2023-07-07 N/A Other Buy 5,300 19,488.10 EUR
2023-07-06 N/A Other Buy 1,100 4,048.00 EUR
2023-07-05 N/A Other Buy 10,000 37,061.00 EUR
2023-07-03 N/A Other Buy 5,300 18,769.95 EUR

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.